Market Tracker

04/23 1:01pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

47.25
BATS BZX Real-Time Price
As of 1:00pm ET
 -1.60 / -3.28%
Today’s Change
29.95
Today|||52-Week Range
50.05
+18.57%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close48.85
Today’s open48.80
Day’s range47.25 - 48.90
Volume16,412
Average volume (3 months)646,401
Market cap$2.3B
Data as of 1:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)-38.64%
Earnings growth (this year)+74.54%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+40.57%
P/E ratio43.9
Price/Sales7.03
Price/Book8.60

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.34-2.39%
PRTAProthena Corporation...-25.23-68.49%
IRWDIronwood Pharmaceuti...+0.25+1.45%
HZNPHorizon Pharma PLC+0.04+0.29%
Data as of 1:01pm ET, 04/23/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)$0.24
Annual revenue (last year)$302.2M
Annual profit (last year)$57.3M
Net profit margin18.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts